Anagrelide

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 434 publications

Gastric intramural hematoma during treatment with aspirin and anagrelide in a patient with essential thrombocythemia

Gastric intramural hematoma during treatment with aspirin and anagrelide in a patient with essential thrombocythemia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: March 29, 2026

Thrombotic and Bleeding Complications in Myeloproliferative Neoplasms: An Integrated Clinical Perspective.

Thrombotic and Bleeding Complications in Myeloproliferative Neoplasms: An Integrated Clinical Perspective.

Journal: Seminars in thrombosis and hemostasis

Published: March 19, 2026

Budd-Chiari Syndrome Secondary to Essential Thrombocythaemia Complicated by Acquired Von Willebrand Disease and Mimicking Hepatic Malignancy: A Case Report.

Budd-Chiari Syndrome Secondary to Essential Thrombocythaemia Complicated by Acquired Von Willebrand Disease and Mimicking Hepatic Malignancy: A Case Report.

Journal: Cureus

Published: December 26, 2025

Five-year population-based study of essential thrombocythemia in Taiwan: Epidemiology, treatment patterns, and sex-based disparities.

Five-year population-based study of essential thrombocythemia in Taiwan: Epidemiology, treatment patterns, and sex-based disparities.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: November 04, 2025

Pharmacologic management of ET: established therapies and emerging agents.

Pharmacologic management of ET: established therapies and emerging agents.

Journal: Expert opinion on pharmacotherapy

Published: October 27, 2025

Bioequivalence and Pharmacokinetics of Low-Dose Anagrelide 0.5 mg Capsules in Healthy Volunteers.

Bioequivalence and Pharmacokinetics of Low-Dose Anagrelide 0.5 mg Capsules in Healthy Volunteers.

Journal: Biomedicines

Published: July 19, 2025

Ropeginterferon alfa-2b in hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia (SURPASS ET): a multicentre, open-label, randomised, active-controlled, phase 3 study.

Ropeginterferon alfa-2b in hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia (SURPASS ET): a multicentre, open-label, randomised, active-controlled, phase 3 study.

Journal: The Lancet. Haematology

Published: June 11, 2025

Leukocytoclastic Vasculitis in JAK2-Positive Essential Thrombocythemia: A Case of Cytokine-Driven Urticarial Rash Responsive to Ruxolitinib.

Leukocytoclastic Vasculitis in JAK2-Positive Essential Thrombocythemia: A Case of Cytokine-Driven Urticarial Rash Responsive to Ruxolitinib.

Journal: European journal of case reports in internal medicine

Published: June 10, 2025

Ruxolitinib and Hydroxycarbamide Are the Most Efficient Drugs to Reduce Aquagenic Pruritus Intensity in a Real-Word Cohort of Patients With Myeloproliferative Neoplasms.

Ruxolitinib and Hydroxycarbamide Are the Most Efficient Drugs to Reduce Aquagenic Pruritus Intensity in a Real-Word Cohort of Patients With Myeloproliferative Neoplasms.

Journal: EJHaem

Published: May 07, 2025

Cytoreductive treatment differentially affects platelet size and cytoskeletal megakaryocyte organization during thrombopoiesis in myeloproliferative neoplasms.

Cytoreductive treatment differentially affects platelet size and cytoskeletal megakaryocyte organization during thrombopoiesis in myeloproliferative neoplasms.

Journal: Experimental hematology

Published: April 28, 2025

An Unusual Case of Essential Thrombocythemia and Acute Kidney Injury: Case Report and Literature Review.

An Unusual Case of Essential Thrombocythemia and Acute Kidney Injury: Case Report and Literature Review.

Journal: Diseases (Basel, Switzerland)

Published: April 05, 2025

Advances in the diagnosis and treatment of thrombocytosis in children

Advances in the diagnosis and treatment of thrombocytosis in children

Journal: Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics

Published: February 18, 2025

Showing 1-12 of 434

Last Updated: 04/28/2026